Stocks / MDT
MDT stock forecast
MEDTRONIC PLC · Healthcare · Medical Devices
Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.
MDT is not among the 20 largest holdings published for 2026 Q4. See the portfolio
MDT against the S&P 500
| Period | MDT | S&P 500 (SPY) |
|---|---|---|
| 1 month | +8.6% | -4.7% |
| 3 months | +7.9% | -4.8% |
| Year to date | +7.5% | +7.9% |
| 1 year | +3.2% | +11.8% |
Total return, dividends included.
Key numbers
| Price | $100.72 |
| Market cap | 128.83 Billion |
| P/E (trailing 12 months) | 24.6 |
| P/S (trailing 12 months) | 3.4 |
| P/B (latest quarter) | 2.4 |
| Gross margin | 65.0% |
| Net profit margin | 13.9% |
| Return on equity | 10.6% |
| Beta | 0.1 |
As of September 3, 2026.
MDT and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| SYK | STRYKER CORP | 121.12 Billion | Greatly Underperform | MDT vs SYK |
| ABT | ABBOTT LABORATORIES | 180.95 Billion | Underperform | ABT vs MDT |
| BSX | BOSTON SCIENTIFIC CORP | 63.26 Billion | Greatly Outperform | MDT vs BSX |
| EW | EDWARDS LIFESCIENCES CORP | 60.51 Billion | Underperform | |
| DXCM | DEXCOM INC | 30.78 Billion | Outperform | |
| STE | STERIS PLC | 25.21 Billion | Greatly Underperform |
Questions
What does the Upfront Investment model say about MDT?
The model rates MEDTRONIC PLC (MDT) "Outperform" as of November 18, 2026, which means its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the MDT rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is MDT in the Upfront Investment model portfolio?
MDT is not among the 20 largest holdings published for 2026 Q4.
The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.